Market closed

ClearPoint Neuro/CLPT

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About ClearPoint Neuro

ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.

Ticker

CLPT
Trading on

Industry

Health Care Equipment & Supplies

Employees

107

ClearPoint Neuro Metrics

BasicAdvanced
$320M
Market cap
-
P/E ratio
-$0.70
EPS
1.12
Beta
-
Dividend rate
$320M
1.12
$12.75
$4.05
153K
2.789
2.239
10.276
42.939
-23.17%
-60.40%
10.565
9.97
10.21
-29.968
29.33%
-17.03%
24.12%
11.11%

What the Analysts think about ClearPoint Neuro

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for ClearPoint Neuro stock.

ClearPoint Neuro Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

ClearPoint Neuro Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy CLPT

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for ClearPoint Neuro stock?

ClearPoint Neuro (CLPT) has a market cap of $320M as of October 13, 2024.

What is the P/E ratio for ClearPoint Neuro stock?

The price to earnings (P/E) ratio for ClearPoint Neuro (CLPT) stock is 0 as of October 13, 2024.

Does ClearPoint Neuro stock pay dividends?

No, ClearPoint Neuro (CLPT) stock does not pay dividends to its shareholders as of October 13, 2024.

When is the next ClearPoint Neuro dividend payment date?

ClearPoint Neuro (CLPT) stock does not pay dividends to its shareholders.

What is the beta indicator for ClearPoint Neuro?

ClearPoint Neuro (CLPT) has a beta rating of 1.12. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.